Kiora Pharmaceuticals (KPRX) Institutional Ownership $2.79 +0.04 (+1.45%) Closing price 04/17/2025 03:50 PM EasternExtended Trading$2.78 -0.02 (-0.54%) As of 04/17/2025 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Kiora Pharmaceuticals (NASDAQ:KPRX)CurrentInstitutional OwnershipPercentage76.97%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$15.47MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$24.30M Get KPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kiora Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KPRX Institutional Buying and Selling by Quarter Kiora Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Rosalind Advisors Inc.250,555$827K0.4%-2.0%8.352% 2/13/2025ADAR1 Capital Management LLC200,221$661K0.1%+1.9%6.674% 2/11/2025Rosalind Advisors Inc.250,555$827K0.4%-2.0%8.352% 8/21/2024Stonepine Capital Management LLC200,000$840K0.8%N/A6.856% 8/20/2024Nantahala Capital Management LLC211,110$887K0.1%-88.9%7.237% 8/7/2024AIGH Capital Management LLC255,561$1.07M0.3%-88.9%8.761% 7/12/2024Rosalind Advisors Inc.255,555$1.07M0.8%-88.9%8.752% 4/25/2024Rosalind Advisors Inc.2,300,000$1.62M1.5%N/A8.759% (Data available from 1/1/2016 forward) KPRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KPRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Kiora Pharmaceuticals shares: AIGH Capital Management LLC ($1.07M), Nantahala Capital Management LLC ($887K), Stonepine Capital Management LLC ($840K), and Rosalind Advisors Inc. ($827K), ADAR1 Capital Management LLC ($661K).Learn more on KPRX's institutional investors. What percentage of Kiora Pharmaceuticals stock is owned by institutional investors? 76.97% of Kiora Pharmaceuticals stock is owned by institutional investors. Learn more on KPRX's institutional investor holdings. Which institutional investors have been buying Kiora Pharmaceuticals stock? The following institutional investors have purchased Kiora Pharmaceuticals stock in the last 24 months: Rosalind Advisors Inc. ($2.30M), Stonepine Capital Management LLC ($200K), and ADAR1 Capital Management LLC ($3.67K). How much institutional buying is happening at Kiora Pharmaceuticals? Institutional investors have bought a total of 2,503,670 shares in the last 24 months. This purchase volume represents approximately $15.47M in transactions. Which Kiora Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Kiora Pharmaceuticals stock in the last 24 months: Rosalind Advisors Inc. ($2.05M), AIGH Capital Management LLC ($2.04M), and Nantahala Capital Management LLC ($1.69M). How much institutional selling is happening at Kiora Pharmaceuticals? Institutional investors have sold a total of 5,787,774 shares in the last 24 months. This volume of shares sold represents approximately $24.30M in transactions. Related Companies Werewolf Therapeutics Institutional Ownership Estrella Immunopharma Institutional Ownership Kezar Life Sciences Institutional Ownership Reviva Pharmaceuticals Institutional Ownership Surrozen Institutional Ownership Marinus Pharmaceuticals Institutional Ownership FibroGen Institutional Ownership MiNK Therapeutics Institutional Ownership Cadrenal Therapeutics Institutional Ownership Allakos Institutional Ownership This page (NASDAQ:KPRX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KPRX Stock Free KPRX Stock Alerts